The ubiquity of p53 in genome-stabilizing functions leads to an aberrant tumor microenvironment in <i>TP53</i>-mutated myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Here, TP53 is linked to myelodysplastic syndrome.